CD74 and lung adenocarcinoma: Therefore, the identified lncRNAs and CD74 could be employed as novel predictive biomarkers or therapeutic targets to increase the effectiveness of targeted therapy and improve the clinical outcomes of patients with lung adenocarcinoma.